Merck & Co., Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 6MK.DE | AZN | PFE | NVS | GSK | JNJ | |
|---|---|---|---|---|---|---|
| Market cap | 326.80B | 261.25B | 170.14B | 292.58B | 100.22B | 621.22B |
| P/E (TTM) | 122.6 | 25.2 | 39.3 | 23.3 | 15.8 | 39.1 |
| Forward P/E | — | 14.9 | 10.3 | 15.7 | 10.2 | 22.2 |
| Price/book | 8.7 | 5.2 | 2.0 | 7.0 | 4.3 | 7.3 |
| Dividend yield | 2.29% | 1.90% | 5.71% | 3.09% | 3.59% | 2.07% |
| 1-year change | +73.00% | +1.17% | +21.80% | +16.90% | +14.39% | +34.43% |
| Today | +0.35% | −0.22% | −0.86% | +0.19% | −1.20% | −0.61% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All 6MK.DE news ›Arcus Dips, But Recovers From Steep Losses, On Merck-Rivaling Cancer Data
Allison Gatlin covers biotechnology, pharmaceuticals and medical technology. She also oversees coverage of top-performing companies for Investor's Business Daily's The New America page. Allison has worked for Investor's Business Daily…
Merck to Hold Third-Quarter 2026 Sales and Earnings Conference Call Oct. 29
October 1, 2026 6:45 am EDT RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its third-quarter 2026 sales and earnings conference call with institutional investors and…
Merck buys Silence and its siRNA pipeline for $1.3bn
Merck KGaA has reached a deal to acquire UK-based Silence Therapeutics in an all-cash, $1.3 billion deal that will boost its presence in RNA-focused drugs and give it a late-stage drug candidate for rare disease polycythemia vera (PV).…
Merck KGaA to buy Silence Therapeutics in all-cash deal
Merck KGaA to acquire Silence Therapeutics for $1.3B cash, a 130% premium, boosting siRNA pipeline and rare-disease focus. Merck KGaA (MKGAY) (MKGAF) has agreed to acquire Silence Therapeutics (SLN) in an all-cash deal with an enterprise…
Merck & Co Inc Stock (MRK) Opened Up by 3.79% on Oct 20: What Signal Does It Send?
TradingKey Merck & Co Inc Stock (MRK) Opened Up by 3.79% on Oct 20: What Signal Does It Send? What is driving Merck & Co Inc (MRK)’s stock price up today? Merck & Co. demonstrated strong upward momentum with heightened intraday trading…
Better Dividend Stock: Merck vs. Bristol Myers Squibb
Pressmaster from Pressmaster and Ri_Ya from pixabay Merck (MRK) and Bristol Myers Squibb (BMY) both raised their 2026 sales outlooks this summer. That’s good news for income investors, since a growing business keeps a dividend growing. The…
Shh! Silence Therapeutics is International Biotechnology’s ninth portfolio bid this year after Merck splashes $1.3bn
Silence Therapeutics, one of the few UK-based holdings of International Biotechnology Trust (IBT), has been acquired by German drugs giant Merck for $1.3bn cash. News of the agreed deal yesterday saw Silence’s US Nasdaq-listed shares soar…
Merck Stock Forecast: MRK Bounces Off 50-Day EMA as ESMO Data and Q3 Earnings Near
My view: Bullish while Merck holds above $142.65. A close above $152 would have me looking for a retest of the $156 peak. Reuters reports that the healthcare sector hit an all-time high on Tuesday as large-cap drugmakers led a rebound from…
Merck buys biotech Silence Therapeutics for USD 1.1bn
Senior Drug Product Filling Specialist Associate Market Access Director – International Markets Senior Drug Substance Scientist Head of Medical Affairs International Markets Chef for Kvalitet og Compliance Head of Clinical Operations…
Merck vs. Amgen: Which Dividend Stock Pays You More in 10 Years?
AtlasStudio from Getty Images via Canva On Aug. 4, Merck (MRK) raised and narrowed its 2026 sales outlook to $66.3 billion to $67.3 billion. The same day, Amgen (AMGN) reported second-quarter revenue up 10% to $10.1 billion. For income…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com28
-
marketbeat.com23
-
gurufocus.com9
-
theglobeandmail.com8
-
tradingview.com8
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.